.AstraZeneca has actually shared a very early check out the efficiency of its own internal antibody-...
.After revealing a phase 3 launch based upon positive midstage results, iTeos and GSK are lastly dis...
.The FDA needs to be extra available and also collaborative to release a surge in approvals of unusu...
.It is actually an uncommonly busy Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicar...
.Atea Pharmaceuticals' antiviral has fallen short another COVID-19 test, yet the biotech still store...
.Neurocrine Biosciences' mental illness program pivot has actually neglected. The biotech was actual...
.Sanofi has actually made an overdue entry to the radioligand party, paying one hundred thousand eur...
.After F2G's initial try to receive a brand-new class of antifungal to market was hindered due to th...
.Moderna has promised to reduce R&D spending by $1.1 billion by 2027. The decision to retract the...
.Merely 4 months after Sanofi bet $80 thousand in ahead of time cash money on Key Therapies' losmapi...